In the present study, after treatment of BEAS-2B cells with E2/GH, the IL-6, MCP-1, MDA and ROS levels were all decreased, and SOD was increased, suggesting that E2/GH treatment alleviated COVID-19-type proinflammatory responses. The gene discussed is GH1; the disease is COVID-19.